Niki BioSolutions, Inc. (NIKI) Balance Sheet

NASDAQ: NIKIAssets, liabilities, debt and equity over 9 years.

NIKI balance sheet, 2025

December 31, 2025 · U.S. dollars

$18.7M assets = $4.9M liabilities + $13.8M equity

What it owns$18.7MCash & ST investments: $3.5M (18.5%)Cash & ST investments$3.5M · 18%Other current: $139,633 (0.7%)LT investments: $15.1M (80.8%)LT investments$15.1M · 81%=How it is financed$18.7MCurrent liabilities: $4.6M (24.6%)Current liabilities$4.6M · 25%Other LT liabilities: $306,000 (1.6%)Shareholders’ equity: $13.8M (73.8%)Shareholders’ equity$13.8M · 74%

Both columns are drawn to the same scale: what NIKI owns equals what it owes plus shareholders’ equity. Hover a block for its value.

NIKI financial health

Current ratio0.78
Tight · current assets cover current liabilities 0.78×
Debt / equity0.15
Low leverage · $0.15 of debt for each $1 of equity
Equity / assets123.9%
Equity-funded · of assets funded by shareholders
Cash / debt100.3%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

NIKI balance sheet trends, 2017–2025

Niki BioSolutions, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$31.6M2017$18.7M2025−6.3%/yr
Total liabilities$1.3M2017$4.9M2025+17.7%/yr
Shareholders’ equity$30.2M2017$23.2M2025−3.3%/yr
Cash & short-term investments$18.2M2017$3.5M2025−18.8%/yr
Total debt$480,0002017$3.4M2025+27.9%/yr
Net cash (debt)$17.7M2017$9,9632025−$17.7M
Working capital$19.0M2017−$1.0M2025−$20.0M
Current ratio15.2420170.782025−14.46
Debt / equity0.0220170.152025+0.13

Change is the average annual growth (CAGR) or the difference between the first and latest year.

NIKI assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

NIKI liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

NIKI debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

NIKI balance sheet

Niki BioSolutions, Inc. annual balance sheet
202520242023202220212020201920182017
Assets
Cash & short-term investments$3.5M$874,238$2.0M$2.0M$8.5M$31.9M$6.3M$13.0M$18.2M
Cash & equivalents$3.5M$874,238$2.0M$1.9M$8.1M$3.5M$5.2M$12.0M$16.2M
Short-term investments——$0$102,481$236,615$28.4M$1.1M$1.0M$2.0M
Receivables$0$4,545$70,945$1.4M$3.6M$341,063$487,590$990,846$179,492
Inventory$0$0$0$27,722$35,775$39,133$34,185$30,642$1.5M
Other current assets$139,633$80,771$399,796$3.7M$593,478$1.4M$1.3M$14.7M$348,573
Total current assets$3.6M$959,554$2.5M$7.1M$12.7M$33.7M$8.0M$28.7M$20.3M
Property, plant & equipment (net)$0$0$1.8M$3.2M$4.0M$5.4M$7.1M$4.3M$346,587
Goodwill & intangible assets$0$0$147,347$752,705$880,256$964,857$1.3M$1.4M$1.5M
Long-term investments$15.1M$15.1M$16.1M$9.7M$0$0$0$0$0
Other non-current assets$0$71,823$71,823$127,303$4.3M$4.2M$7.5M$10.7M$9.5M
Total assets$18.7M$16.1M$20.6M$20.9M$21.9M$44.2M$24.0M$45.1M$31.6M
Liabilities
Accounts payable———————$40,139—
Short-term debt$3.4M$3.3M$125,232$6.3M$398,017$1.1M$46,555$10.2M$480,000
Deferred revenue———————$1.2M—
Total current liabilities$4.6M$4.3M$2.1M$12.5M$4.4M$3.9M$2.7M$12.2M$1.3M
Long-term debt$0$0$3.1M$500,000$0$0$0$0$0
Lease obligations$24,428$116,407$224,717$341,332—————
Other long-term liabilities$306,000$14,182$99,485$30,784$23,853$2.2M$6.4M$143,873$0
Total liabilities$4.9M$4.4M$5.3M$13.0M$4.4M$6.1M$9.1M$12.3M$1.3M
Shareholders' equity
Common stock & paid-in capital$80$55$53$35.7M$35.6M$34.0M$29.0M$29.0M$27.9M
Retained earnings (deficit)−$73.8M−$72.4M−$68.2M−$65.3M−$55.5M−$30.5M−$37.6M−$17.4M−$2.5M
Accumulated other comprehensive income−$92,310$89,162−$10,623$33,807−$2,019$53,296−$5,552−$1.5M−$367,782
Minority interest−$9.4M−$9.4M−$9.5M−$7.9M—————
Total shareholders' equity$23.2M$21.1M$24.8M$15.7M$23.6M$41.8M$16.4M$33.1M$30.2M
Key figures
Total debt$3.4M$3.4M$3.3M$6.9M$217,167$3.3M$6.5M$10.3M$480,000
Net cash (debt)$9,963−$2.5M−$1.3M−$4.9M$8.3M$28.6M−$222,232$2.7M$17.7M
Working capital−$1.0M−$3.4M$377,339−$5.4M$8.3M$29.8M$5.4M$16.5M$19.0M
Tangible book value$23.2M$21.1M$24.7M$15.0M$22.7M$40.9M$15.0M$31.7M$28.8M
Current ratio0.780.221.180.572.908.703.002.3615.24
Quick ratio0.750.200.990.272.758.332.521.1513.83
Debt / equity0.150.160.130.440.010.080.400.310.02
Equity / assets123.9%131.0%120.4%75.3%107.8%94.6%68.3%73.5%95.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2026); data from EODHD.

NIKI financial position

At the end of fiscal 2025 (December 31, 2025), Niki BioSolutions had total assets of $18.7 million (up 15.9% from a year earlier), total liabilities of $4.9 million and shareholders' equity of $23.2 million. It held $3.5 million in cash and short-term investments against $3.4 million of debt, a net cash position of $0.0 million. Its current ratio was 0.78.

Related: NIKI income statement, NIKI cash flow statement, NIKI key metrics. See the NIKI stock overview for the latest quote and news.

NIKI balance sheet FAQ

What are Niki BioSolutions's total assets?

Niki BioSolutions reported total assets of $18.7 million at the end of fiscal 2025 (December 31, 2025), compared with $16.1 million a year earlier.

How much debt does Niki BioSolutions have?

Niki BioSolutions had $3.4 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.15.

How much cash does Niki BioSolutions have?

Niki BioSolutions held $3.5 million in cash and short-term investments at the end of fiscal 2025; with $3.4 million of debt that is net cash of $0.0 million.

What is Niki BioSolutions's book value?

Niki BioSolutions's shareholders' equity (book value) was $23.2 million at the end of fiscal 2025.

What is Niki BioSolutions's current ratio?

Niki BioSolutions had current assets of $3.6 million and current liabilities of $4.6 million, a current ratio of 0.78 (current liabilities exceed current assets).

Biotechnology: balance sheet